Company facts
- Headquarters
- New York, New York
- Most recent report
- 10-Q, filed Oct 21, 2026
- Incorporated
- Delaware
- Filings on record
- 1,007+ filings
- On EDGAR
- CIK 1059556
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 32
News 8 of 89
Prospectuses and Registrations 8 of 38
- FWP Free writing prospectus Nov 9, 2026
- 424B5 Prospectus supplement for an offering Nov 9, 2026
- S-8 Registration statement for an employee plan Jul 24, 2026
- S-8 Registration statement for an employee plan Feb 20, 2026
- S-3ASR Automatic shelf registration Feb 19, 2026
- 424B2 Prospectus supplement for an offering Jul 31, 2024
- FWP Free writing prospectus Jul 29, 2024
- 424B5 Prospectus supplement for an offering Jul 29, 2024
Proxies 8 of 21
- DEFA14A Extra proxy material Mar 4, 2026
- DEF 14A Proxy statement for a shareholder vote Mar 4, 2026
- DEFA14A Extra proxy material Mar 5, 2025
- DEF 14A Proxy statement for a shareholder vote Mar 5, 2025
- DEFA14A Extra proxy material Mar 6, 2024
- DEF 14A Proxy statement for a shareholder vote Mar 6, 2024
- PRE 14A Preliminary proxy statement Feb 23, 2024
- DEFA14A Extra proxy material Mar 8, 2023
Ownership 8 of 811
- 144 Notice of a proposed sale of restricted stock Nov 9, 2026
- 4 Insider reported a trade Nov 6, 2026
- 4 Insider reported a trade Nov 5, 2026
- 144 Notice of a proposed sale of restricted stock Nov 5, 2026
- 144 Notice of a proposed sale of restricted stock Nov 4, 2026
- 4 Insider reported a trade Nov 3, 2026
- 4 Insider reported a trade Nov 3, 2026
- 4 Insider reported a trade Nov 3, 2026
Other 8 of 16
- 305B2 Nov 9, 2026
- 11-K Employee stock plan report Jun 25, 2026
- ARS Annual report sent to shareholders Mar 4, 2026
- 11-K Employee stock plan report Jun 23, 2025
- ARS Annual report sent to shareholders Mar 5, 2025
- 11-K Employee stock plan report Jun 26, 2024
- ARS Annual report sent to shareholders Mar 6, 2024
- 11-K Employee stock plan report Jun 14, 2023
What to read: Sep 2026 10-Q
SECSift found 4 of 11 sections worth reading, with 0 positive, 10 notable, and 0 negative flags.
Financial Statements (Item 1)
Financial statements and notes with material balance-sheet, cash-flow, and segment details.Management's Discussion (Item 2)
Full MD&A with segment results, cash flow, debt, and non-GAAP reconciliations.Market Risk (Item 3)
New cross-currency swaps entered; updated sensitivity table with specific notional and FX impact amounts.Notable- New cross-currency swaps entered in nine months ended September 30, 2026, with $450M euro sensitivity.
- If HKD strengthens 10% vs USD, $50M unfavorable OCI impact on cross-currency swaps.
- If SGD strengthens 10% vs HKD, $30M unfavorable OCI impact on cross-currency swaps.
- Euro-denominated debt of €1.25B designated as net investment hedge; $140M OCI impact if euro strengthens 10%.
Unregistered Sales and Repurchases (Item 2)
Buyback pace and remaining $1.4B authority are material to capital allocation.
What changed: Sep 2026 vs. Jun 2026
About 9% of MCO's Sep 2026 10-Q is new information. 58 paragraphs were added, 251 changed, and 44 removed. Below are the most important lines SECSift identified.
Everything here comes from Moodys Corp's own filings on SEC EDGAR. The filing list is rechecked every hour. SECSift analysis was completed on Oct 21, 2026, from the 10-Q for Sep 2026.